Functional variation in human CAZyme genes in relation to the efficacy of a carbohydrate-restricted diet in IBS patients
Andreea Zamfir-Taranu,Britt-Sabina Löscher,Florencia Carbone,Abdullah Hoter,Cristina Esteban Blanco,Isotta Bozzarelli,Leire Torices,Karen Routhiaux,Karen Van den Houte,Ferdinando Bonfiglio,Gabriele Mayr,Maura Corsetti,Hassan Y. Naim,Andre Franke,Jan Tack,Mauro D’Amato
DOI: https://doi.org/10.1016/j.cgh.2024.09.004
IF: 13.576
2024-10-16
Clinical Gastroenterology and Hepatology
Abstract:Background and aims Limiting the dietary intake of certain carbohydrates has therapeutic effects in some but not all irritable bowel syndrome (IBS) patients. We investigated genetic variation in human Carbohydrate-Active enZYmes (hCAZymes) genes in relation to the response to a FODMAP-lowering diet in the DOMINO study. Methods HCAZy polymorphism was studied in IBS patients from the dietary (FODMAP-lowering; N=196) and medication (otilonium bromide; N=54) arms of the DOMINO trial via targeted sequencing of 6 genes of interest ( AMY2B , LCT , MGAM , MGAM2 , SI and TREH ). hCAZyme defective (hypomorphic) variants were identified via computational annotation using clinical pathogenicity classifiers. Age- and sex-adjusted logistic regression was used to test hCAZyme polymorphisms in cumulative analyses where IBS patients were stratified into carrier and non-carrier groups (collapsing all hCAZyme hypomorphic variants into a single bin). Quantitative analysis of hCAZyme variation was also performed, in which the number of hCAZyme genes affected by a hypomorphic variant was taken into account. Results In the dietary arm, the number of hypomorphic hCAZyme genes positively correlated with treatment response rate ( P =.03, OR=1.51 [CI=0.99-2.32]). In the IBS-D group (N=55), hCAZyme carriers were six times more likely to respond to the diet than non-carriers ( P =.002, OR=6.33 [CI=1.83-24.77]). These trends were not observed in the medication arm. Conclusions HCAZYme genetic variation may be relevant to the efficacy of a carbohydrate-lowering diet. This warrants additional testing and replication of findings, including mechanistic investigations of this phenomenon.
gastroenterology & hepatology